Latest News

KDM1 may represent a new therapeutic target for glioma

Researchers have generated preclinical data demonstrating that the protein KDM1, which functions as a lysine demethylase, is a potential target for glioma treatment, according to new research.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • S100B protein in diagnosing intracranial hemorrhage in some patients with mild head injury

  • 'Here comes the sun': Does pop music have a 'rhythm of the rain?'

  • Researcher disputes claim that humans can distinguish one trillion odors

  • Typically disregarded brain lesions may warn of heightened stroke risk

  • Nanomedicine in the fight against thrombotic diseases

  • Increased risk of complications, death during delivery for women with epilepsy

  • Cognitive behavioral therapy for insomnia with psychiatric, medical conditions

  • Reducing stroke damage may be next for optical coherence tomography technology widely used in vision healthcare

  • Restraint, confinement still an everyday practice in mental health settings

  • Age-related cognitive decline tied to immune-system molecule

  •